SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Carbylan BioSurgery, Inc. Completes Enrollment in Key Clinical Feasibility Study of Hydros and Hydros TA in Patients With Pain From Knee Osteoarthritis; Core Patent Issued